speakerspeaker

Global partnerships formed during the Covid-19 era

Coronavirus brings attention to the fast-growing $35bn vaccine market.

Read more here

New vaccine delivery technologies for better immune response

Clinical trials show delivery of vaccines via new techniques induces greater immune responses than traditional methods.

Secure your place

Exploring new genetic-engineering technologies for vaccine development

Hear the latest case studies in messenger RNA technologies for next-generation vaccines.

View the latest program

Expert Speakers to Date

  • Yongxiu Yao
    The Pirbright Institute
  • Tom Tillett
    MBF Therapeutics
  • Sushant Sahastrabuddhe
    International Vaccine Institute
  • Kevin Killeen
    Matrivax Corporation
  • Anh Wartel,
    International Vaccine Institute
  • Anna Särnefält
    CEPI
  • Jasmin Samaras
    University College London
  • Antonio Roldao
    iBET
  • Philip Probert
    Centre for Process Innovation Limited
  • Gregory Tobin
    Biological Mimetics

Past Attendees

  • Cytiva formerly GE Healthcare
  • Biological Mimetics
  • MERCK
  • CanSino Biologics
  • MBF Therapeutics
  • Matrivax Corporation
  • International Vaccine Institute
  • CEPI
  • Technical University of Denmark
  • The Pirbright Institute
  • VBI Vaccines
  • CPI
  • iBET
  • University College London
  • Harvard University
  • Bill & Melinda Gates Foundation

Who should attend

  • Vaccine Delivery Platforms
  • Clinical Trials and Approvals
  • Vaccine Development
  • Biological Engineering of Vaccines
  • Immunization Research & Development
  • Vaccine Manufacturing
  • Structural Vaccinology Projects
  • Manufacturing Research & Innovation
  • Vaccine Technologies
  • Advanced Live-Attenuated Vaccines
  • Research and Development
  • Genetic Engineering
  • Inactivated Vaccine Development
  • Strategy, Projects, & Public Affairs
  • DNA, mRNA Technologies
  • Cost Reduction Strategies
  • Legal and Compliance Work
  • Viral Vector-based Vaccines
  • Sales and Marketing Initiatives
  • Equipment Certification Services
  • Nucleic Acid-Based Vaccines
  • Business Development
  • News Reporting and Journalism

Why Attend

The Vaccine Technology Summit 2022 is the only event of its kind to deliver leading market intelligence and industry presentations on the latest in new vaccine technologies and techniques for the discovery, development, and manufacturing of next-generation vaccines…

view more...

The Premier Forum for Global Vaccine Technologies

Welcome to the Vaccine Technology Summit 2022, where global biotech and pharmaceutical companies will meet with leading vaccine experts in London, UK, to explore new vaccine technologies to discover, develop, and manufacture next-generation vaccines.

As today’s vaccine developers continue to learn from the global outbreak of SARS-CoV-2 and diseases of the past, it is of critical importance that leading institutions and experts unite and collaborate in developing cures, from the initial discoveries and clinical trials to the manufacturing process of new vaccines to meet the needs of the human population.

Global leaders in vaccines are fast developing a wide array of new technologies, from targeted attenuation techniques to the delivery of biologically-engineered proteins, viral vectors, and nucleic acid-based vaccines - many of which technologies have offered promising results for vaccine development.

This year’s Vaccine Technology Summit 2022 event is set to become the world’s leading exhibition and conference exclusively for the vaccine industry, to meet and collaborate with a large array of vaccine experts and institutions, to examine new vaccination technologies and technical know-how, and to discuss the fundamental challenges associated with discovery, development, and manufacturing of next-generation vaccines.

Key topics on this year’s agenda include:

  • The fundamentals of new vaccine discovery and development
  • Exploring new technologies in vaccine delivery for better immune responses
  • Latest research in genetically-engineered vaccinations and mRNA vaccine technologies
  • New developments in viral vectors, nucleic acid-based vaccines, and structural vaccinology
  • Advances in live-attenuated virus vaccines and lessons learnt from inactivated vaccines
  • Case studies and clinical trials and working with global vaccine manufacturers

This event will provide a forum for all stakeholders across the biotech and pharmaceutical industry, from leading vaccine developers to manufacturers to network and build cross-market relationships to explore new technologies and technical know-how to address the global challenges in vaccine development.

Call for Presentation

If you would like to be a speaker at this event, please contact sean.collins@iQ-Hub.com, subject heading "Call for Papers - Vaccine Technology Summit 2022".

Book now
To secure your place at Vaccine Technology Summit 2022 or if you require more information, please contact delegates@iQ-Hub.com.

SPONSORS / EXHIBITORS

Key topics for 2022:

  • The fundamentals of new vaccine discovery and development
    Understand biotech and pharmaceutical industry fundamentals and key market drivers for developing vaccinations from a global perspective.
  • Exploring new technologies in vaccine delivery for better immune responses
    Look for new opportunities and make the clinical case for adopting new technology and techniques for vaccine delivery.
  • Latest research in genetically-engineered vaccinations and mRNA vaccine technologies
    Explore new innovations and assess the latest results from tests and trials in biologically-engineered vaccinations and new advancements in DNA and messenger RNA vaccination technologies.
  • New developments in viral vectors, nucleic acid-based vaccines, and structural vaccinology
    Future vaccination strategies and the latest advancements in viral vector-based applications for adapting structural viral vaccine design and development.
  • Advances in live-attenuated virus vaccines and lessons learnt from inactivated vaccines
    Hear from leading vaccine developers and build on traditional vaccine approaches for cost-effective and proven methods for developing new vaccines.
  • Case studies and clinical trials and working with global vaccine manufacturers
    Gain insight from leading manufacturers and implement strategies that others in the industry use to ensure successful vaccine delivery.

Subscribe for updates:

Back to Top
MEET THE VACCINE LEADERS:
  SAVE £200, Book Now!